What is the Optimal Duration of a Short-term Antidepressant Trial When Treating Geriatric Depression?

Background: To determine the optimal duration of an antidepressant trial in elderly patients, the authors examined the probability of eventually responding to treatment based on early improvement. Methods: Four hundred seventy-two elderly patients with major depression (nonpsychotic, nonbipolar) were treated under protocolized conditions for up to 12 weeks and assessed weekly with the Hamilton Rating Scale for Depression. The probability of full response after 12 weeks of treatment was calculated in patients who had not fully responded after periods of treatment that lasted for 4 to 10 weeks. Results: Most of the patients who had shown a partial improvement after 4 weeks of treatment became full responders after 4 or more additional weeks of treatment. By contrast, only a few of those who were nonresponders became full responders even after up to 8 additional weeks of treatment. Conclusions: After 4 weeks of treatment, it is possible to reliably identify a subgroup of elderly patients with depression who are more likely to benefit from a change in their treatment than from a few additional weeks of treatment with the same agent.

[1]  B. Mulsant,et al.  Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. , 2004, The Journal of clinical psychiatry.

[2]  B. Pollock,et al.  Achieving Long-Term Optimal Outcomes in Geriatric Depression and Anxiety , 2003, CNS Spectrums.

[3]  Nicole A. Lazar,et al.  Statistical Analysis With Missing Data , 2003, Technometrics.

[4]  B. Lebowitz,et al.  Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. , 2003, Archives of general psychiatry.

[5]  J. Amsterdam,et al.  When should a trial of fluoxetine for major depression be declared failed? , 2003, The American journal of psychiatry.

[6]  A. Flint.  Treatment-resistant Depression in Late Life , 2002, CNS Spectrums.

[7]  H. Sackeim,et al.  Clinical trials in late-life depression: revisited. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[8]  G. Alexopoulos,et al.  Predictors of early recovery from major depression among persons admitted to community-based clinics: an observational study. , 2002, Archives of general psychiatry.

[9]  Mark D. Miller,et al.  Course and rate of antidepressant response in the very old. , 2002, Journal of affective disorders.

[10]  I. Katz,et al.  Pharmacotherapy of Depression in Older Patients: A Summary of the Expert Consensus Guidelines , 2001, Journal of psychiatric practice.

[11]  S Mazumdar,et al.  A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients. , 2001, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[12]  M. Fava,et al.  Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial. , 2001, The Journal of clinical psychiatry.

[13]  I. Katz,et al.  Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm , 2001, International journal of geriatric psychiatry.

[14]  A. Gelenberg,et al.  How fast are antidepressants? , 2000, The Journal of clinical psychiatry.

[15]  K. Krishnan,et al.  A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. , 2000, The Journal of clinical psychiatry.

[16]  David E. Booth,et al.  Analysis of Incomplete Multivariate Data , 2000, Technometrics.

[17]  C. Clary,et al.  Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. , 2000, The American journal of psychiatry.

[18]  D. Kupfer,et al.  Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. , 1999, The American journal of psychiatry.

[19]  D J Kupfer,et al.  Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. , 1999, JAMA.

[20]  Nelson Jc.  Treatment of antidepressant nonresponders: augmentation or switch? , 1998 .

[21]  D J Kupfer,et al.  Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. , 1997, Archives of general psychiatry.

[22]  M. Thase,et al.  Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline. , 1997, The Journal of clinical psychiatry.

[23]  F. Quitkin,et al.  Can the Effects of Antidepressants Be Observed in the First Two Weeks of Treatment? , 1996, Neuropsychopharmacology.

[24]  D. Kupfer,et al.  Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients. , 1996, The American journal of psychiatry.

[25]  D. Klein,et al.  Chronological milestones to guide drug change. When should clinicians switch antidepressants? , 1996, Archives of general psychiatry.

[26]  M. Tohen,et al.  Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline? , 1996, The Journal of clinical psychiatry.

[27]  A. Flint,et al.  The effect of sequential antidepressant treatment on geriatric depression. , 1996, Journal of affective disorders.

[28]  M. Fava,et al.  Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. , 1995, The American journal of psychiatry.

[29]  J. Feighner,et al.  Venlafaxine for treatment-resistant unipolar depression. , 1994, Journal of clinical psychopharmacology.

[30]  J. Stewart,et al.  Duration of antidepressant trials: clinical and research implications. , 1994, Journal of clinical psychopharmacology.

[31]  Sati Mazumdar,et al.  Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale , 1992, Psychiatry Research.

[32]  P. Grof,et al.  The clinical meaning of refractory depression: a review for the clinician. , 1991, The American journal of psychiatry.

[33]  J. Fleiss,et al.  Heterogeneity of clinical response during placebo treatment. , 1991, The American journal of psychiatry.

[34]  A. Georgotas,et al.  The additional benefit of extending an antidepressant trial past seven weeks in the depressed elderly , 1989 .

[35]  T. Cooper,et al.  Factors affecting the delay of antidepressant effect in responders to Nortriptyline and Phenelzine , 1989, Psychiatry Research.

[36]  L. Jarvik,et al.  Antidepressant drug studies, 1964 to 1986: empirical evidence for aging patients. , 1988, Journal of clinical psychopharmacology.

[37]  J. Mann,et al.  Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors. , 1983, Biological psychiatry.

[38]  J. Endicott,et al.  A diagnostic interview: the schedule for affective disorders and schizophrenia. , 1978, Archives of general psychiatry.

[39]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[40]  W. C. Ellerbroek.  The Diagnostic Interview , 1971 .

[41]  M. Hamilton,et al.  Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.

[42]  B. Mulsant,et al.  Time Course of Response to Antidepressants in Late-Life Major Depression , 2004, Drugs & aging.

[43]  J. Nelson.  Treatment of antidepressant nonresponders: augmentation or switch? , 1998, The Journal of clinical psychiatry.